Prevalence and risk factors of urinary schistosomiasis in the North Dayi and Krachi West districts of Ghana

Schistosomiasis, affects over 250 million people globally, with 90 percent of cases occurring in sub-Saharan Africa. Ghana's Mass Drug Administration (MDA) of praziquantel since 2008 has reduced the prevalence of schistosomiasis butsome areas continue to report high prevalence. This study assessed the prevalence and risk factors associated with urinaryschistosomiasis in the North Dayi and Krachi West Districts of Ghana